Abnormal Bioenergetics in the 1st episode Schizophrenia, Preliminary Studied by the Magnetization Transfer 31P-MRS

In vivo probes of cerebral bioenergetics have the capacity to provide crucial information to characterize the exact abnormalities and delineate their relationships with pathophysiology and symptom presentation of schizophrenia. Using novel 31P-MT-MRS and both 1st-episode and chronic patients, our findings indicate schizophrenia may be characterized by an initial active phase of excessive glutamatergic neurotransmission and bioenergetic activity, which then progressively becomes downregulated and result in decreased intracellular pH in the chronic condition. Our findings provide insight into the progression of schizophrenia and highlight the value of using cerebral activity and bioenergetic metabolism as new biomarkers of the pathophysiology of schizophrenia.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.